Aroa Biosurgery Limited (ARX.AX)
Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Dr. Brian Ward | Founder, CEO, MD & Executive Director | 672.17k | -- | -- |
| Mr. James Agnew BCom, LLB | CFO & Joint Company Secretary | 349.86k | -- | -- |
| Mr. Scott Sherriff B.A., M.B.A. | Chief Operating Officer | -- | -- | -- |
| Dr. Barnaby C.H. May Ph.D. | Chief Scientific Officer | -- | -- | -- |
| Ms. Neetha Alex-Kumar | General Counsel | -- | -- | -- |
| Mr. Frazer Murray | Director of Global Marketing & Strategy | -- | -- | -- |
| Ms. Yasmin Winchester B.Sc. | Vice President of Quality, Regulatory & Sustainability | -- | -- | -- |
| Ms. Tracy Weimar BA, MBA | Joint Company Secretary | -- | -- | -- |
Aroa Biosurgery Limited
- Sector:
- Healthcare
- Industry: Medical Devices
Description
Aroa Biosurgery Limited, a regenerative medicine company, engages in the developing, manufacturing, and sells medical devices for wound and tissue repair using extracellular matrix (ECM) technology in the United States and internationally. Its products include Endoform Natural and Endoform Antimicrobia Restorative Bioscaffold for treating acute and chronic wounds; Myriad Matrix, an engineered ECM for soft tissue repair, reinforcement, and complex wounds; Myriad Morcells, a morcellized (powdered) format of Myriad Matrix for soft tissue repair and complex wounds; and Reinforced Bioscaffolds, a surgical product for use in ventral hernia repair and abdominal wall reconstruction. The company was incorporated in 2007 and is headquartered in Auckland, New Zealand.
Corporate Governance
Recent Events
Recent Events Information Not Available